Tesamorelin
Stabilized GHRH analog studied in growth-hormone/IGF-1 axis and visceral-adipose research models.
Overview
Tesamorelin is a stabilized analog of growth-hormone-releasing hormone (GHRH) with an extended research half-life relative to native GHRH.
It is studied in metabolic and body-composition research, particularly models examining visceral adipose tissue and the growth-hormone/IGF-1 axis.
Mechanism of interest
- GHRH receptor agonism — stimulates endogenous growth-hormone release from the pituitary in research models.
- GH/IGF-1 axis — studied for downstream effects on IGF-1 signaling.
- Visceral-fat models — investigated for its association with visceral adipose tissue endpoints in the literature.
Research areas
Handling & storage
- Lyophilized powder. Store sealed vials at -20°C, protected from light.
- Reconstitute with bacteriostatic water; refrigerate at 2–8°C after reconstitution.
- Avoid repeated freeze/thaw cycles.
Certificates of Analysis
Batch-specific purity, independently verified by HPLC.
| Lot | Purity | Method | Date | COA |
|---|---|---|---|---|
MJBTS Vanguard Laboratory (ISO 17025) | 99.06% | HPLC-UV/VIS | 2025-11 | Download ↓ |
Selected references
- 1.Falutz J, et al. Metabolic effects of a growth hormone-releasing factor (tesamorelin) in patients with excess abdominal fat. N Engl J Med. 2007.
Order
Buy direct from Regenix.
Pricing & direct checkout launching soon — add to cart to save your selection.
Want it now? Buy direct
We'll refer you to one of our preferred providers — they complete your medical qualification and submit it to a licensed physician.
Request direct purchase →All products are sold for laboratory and research use only. Not for human consumption, diagnosis, treatment, or cure of any condition. Not evaluated by the FDA.